"Type 2 Diabetes (T2D) - Pipeline Analysis by Market Research Report Store", for this report sample, please email at: [email protected]

MarketResearchReportStore adds "Type 2 Diabetes (T2D) - Pipeline Analysis" latest studies, published in February 2017. It is a professional and in-depth study.

Description
“Type 2 Diabetes (T2D) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of T2D. The report covers all the drugs being developed in various phases (Discovery, Preclinical, Clinical & Marketing). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, monoclonal antibodies, stem cell therapies, Gene therapies, Recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations. The report also covers some of the hot targets in research for T2D treatments and disease progression biomarkers.
This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Type 2 Diabetes (T2D) Drug market. The report also provide strategic insights on medicines that are likely to have an impact on T2D treatment space and potentially alter standards of care in T2D in the foreseeable future.
Current therapies are focused on the treatment of hyperglycemia than on pancreatic Beta cell dysfunction and they lose efficacy over time as both endogenous insulin secretion and insulin sensitivity decrease. There is a need for type 2 diabetes therapies that act in concert with available agents to provide adequate glycemic control without causing hypoglycemia and weight gain, which are associated with increase in cardiovascular risk. Hence, it provides a tremendous opportunity for upcoming therapies specific to T2D such as MAbs, stem cell-based, gene therapies and RNA-based therapies. These modalities may provide beta-cell protection, regeneration, mass increase with additional benefits of weight loss, triglyceride lowering and kidney protection.

Request Sample Copy, please email at: [email protected]

Table Of Contents
REPORT DESCRIPTION INTRODUCTION
• Causes & Symptoms
• Diagnosis
• Unmet needs
• Epidemiology
• Current therapies
HOT TARGETS, MECHANISMS & THERAPIES
• Novel Disease mechanisms & therapies
• Leading & hot targets of T2DM
• Novel targets of Diabetes
• T2D disease progression biomarkers
MARKET DATA
• Forecasting model
• Market dynamics
• Market sizing
• Cost burden
PIPELINE ANALYSIS
• Development stage
• Leading players
• Therapeutic segmentation
• Innovative approaches
• Target analysis
Small molecules
• Pipeline
• Competitive landscape Large molecules
• Pipeline
• Competitive landscape MONOCLONAL ABs
• Pipeline
• Competitive landscape STEMCELL THERAPY
• Pipeline
• Competitive landscape RNA BASED THERAPEUTICS
• Pipeline
• Competitive landscape GENETHERAPY
• Pipeline
• Competitive landscape
RECOMBINANT FUSION PROTEINS
• Pipeline
• Competitive landscape
DRUG ANALYSIS BASED ON MECHANISM
MAJOR PLAYERS
• Company Profiles
• Overview, Pipeline & Deals
REFERENCES

Browse Complete Report @
https://www.marketresearchreportstore.com/shop/type-2-diabetes-t2d-pipeline-analysis-4

For report sample or more information, please feel free to contact us:
Shirley | Sales Director
Call: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store ( MRRS )
Market Research Report Store (MRRS) is a market research report sales website that works with many of the world’s largest market report publishers,we provide a variety of market report to our customers who from US,Germany,UK,Russia,Japan, Korea,India,Italy,China etc.